Bio like drugs- just as good, much cheaper

被引：0
作者：
Goll, Guro Lovik [1 ,2 ,3 ]
机构：
[1] Diakonhjemmet Sykehus, Revmatol, Oslo, Norway
[2] Diakonhjemmet Sykehus, Revmatol Avdeling, Oslo, Norway
[3] NOR SWITCH Studien, Revmatol, Oslo, Norway
来源：
TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING | 2019年 / 139卷 / 06期
关键词：
BIOSIMILARS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：496 / 496
页数：1
相关论文
共 8 条
  • [1] [Anonymous], 2019, IMP BIOS COMP EUR
  • [2] [Anonymous], 2019, LEG MOT BET LEDD TAR
  • [3] Ballari A., 2019, HELSEFORETAKENE KAN
  • [4] ECCO Position Statement on the Use of Biosimilars for Inflammatory Bowel Disease-An Update
    Danese, Silvio
    Fiorino, Gionata
    Raine, Tim
    Ferrante, Marc
    Kemp, Karen
    Kierkus, Jaroslaw
    Lakatos, Peter L.
    Mantzaris, Gerassimos
    van der Woude, Janneke
    Panes, Julian
    Peyrin-Biroulet, Laurent
    [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 (01) : 26 - 34
  • [5] Switching from originator infliximab to biosimilar CT-P13 compared with maintained treatment with originator infliximab (NOR-SWITCH): a 52-week, randomised, double-blind, non-inferiority trial
    Jorgensen, Kristin K.
    Olsen, Inge C.
    Goll, Guro L.
    Lorentzen, Merete
    Bolstad, Nils
    Haavardsholm, Espen A.
    Lundin, Knut E. A.
    Mork, Cato
    Jahnsen, Jorgen
    Kvien, Tore K.
    [J]. LANCET, 2017, 389 (10086) : 2304 - 2316
  • [6] Biosimilars in rheumatology: the wind of change
    Schneider, Christian K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 (03) : 315 - 318
  • [7] Subjective Complaints as the Main Reason for Biosimilar Discontinuation After Open-Label Transition From Reference Infliximab to Biosimilar Infliximab
    Tweehuysen, Lieke
    van den Bemt, Bart J. F.
    van Ingen, Iris L.
    de Jong, Alphons J. L.
    van der Laan, Willemijn H.
    van den Hoogen, Frank H. J.
    den Broeder, Alfons A.
    [J]. ARTHRITIS & RHEUMATOLOGY, 2018, 70 (01) : 60 - 68
  • [8] Reviewing the evidence for biosimilars: key insights, lessons learned and future horizons
    Uhlig, Till
    Goll, Guro L.
    [J]. RHEUMATOLOGY, 2017, 56 : 49 - 62
1